Ads
related to: Psoriatic Arthritis Medicine- About Plaque Psoriasis
Information On Plaque Psoriasis.
Learn About A Therapy Option.
- Before & After
See Results In Photos Of
Real Patients.
- About Psoriasis
Information On Plaque Psoriasis
& Options Available For Treatment.
- Therapy Information
Alternate Therapy For Plaque
Psoriasis.
- Patient Resources
Get Tools, Personalized Info,
Talk to a Nurse and More.
- Patient Support Program
Don't Be Alone With Psoriasis. Find
Out More About Help You Can Get.
- About Plaque Psoriasis
Search results
Two Biosimilars Approved in Europe for Autoimmune Disorders
Medscape· 15 hours agoThe drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn's...
Arthritis Medications: NSAIDs, Steroids, Narcotics, Topical Treatments, and More
WebMD· 24 hours agoThere are dozens of medications available with or without a prescription to treat the various forms of arthritis. Nonsteroidal anti-inflammatory drugs or NSAIDs are available both over the counter and by prescription.
Brooklyn FI LLC Trims Stake in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 6 days agoBrooklyn FI LLC trimmed its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 13.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission ( ...
Takeda Pharmaceutical: A Long-Term Cash Cow
GuruFocus.com via Yahoo Finance· 3 days agoSource: Takeda Pharmaceutical. Conclusion Takeda is one of the leaders in the global gastrointestinal and cancer therapeutics markets, which is...
Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening...
Morningstar· 5 days agoAd hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Pyzchiva® approved as one of first ustekinumab biosimilars in EuropeEC approval based on robust development program confirming ...
LifePlan Financial LLC Acquires Shares of 1,452 Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 5 days agoLifePlan Financial LLC acquired a new stake in Johnson & Johnson (NYSE:JNJ – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities ...
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed...
Benzinga· 2 days agoThe confirmatory clinical safety and efficacy study for AVT05, biosimilar candidate to Simponi® and Simponi Aria® (golimumab), met its primary endpoint in patients with moderate to severe rheumatoid
Ads
related to: Psoriatic Arthritis Medicine